INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $196,000 | – | 42,400 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
| Front Row Advisors LLC | 60 | $0 | 0.00% |
| Executive Wealth Management, LLC | 20 | $0 | 0.00% |
| BARCLAYS PLC | 1,300 | $0 | 0.00% |
| BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
| Vectors Research Management, LLC | 505 | $0 | 0.00% |